Previous Article | Next Article 
Infect Immun, March 1998, p. 1233-1236, Vol. 66, No. 3
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Transforming Growth Factor
and
Immunosuppression in Experimental Visceral Leishmaniasis
Virmondes
Rodrigues Jr.,1,*
João
Santana da
Silva,2 and
Antonio
Campos-Neto3,4,*
Immunology Laboratory, Medical School of
Triângulo Mineiro, Uberaba,1 MG,
Department of Immunology, Medical School of Ribeirão
Preto, Ribeirão Preto,2 SP, and
Medical School of Itajubá,3 MG,
Brazil, and
Infectious Disease Research Institute, Seattle,
Washington 981044
Received 26 September 1997/Returned for modification 13 November
1997/Accepted 3 December 1997
Hamsters infected with Leishmania donovani develop a
disease similar to human kala-azar. They present
hypergammaglobulinemia, and their T cells do not respond to parasite
antigens. This unresponsiveness has been primarily ascribed to defects
in antigen-presenting cells (APCs), because these cells are unable to
stimulate proliferation of parasite-specific T cells from immunized
animals. In this study, we show that APCs (adherent spleen cells) from
L. donovani-infected hamsters produce high levels of the
inhibitory cytokine transforming growth factor
(TGF-
).
Immunohistochemical studies with an anti-TGF-
monoclonal antibody
(MAb) showed that this cytokine is abundantly produced in vivo by the
spleen cells of infected animals. In addition, high levels of TGF-
are produced in vitro by infected hamster cells, either spontaneously
or after stimulation with parasite antigen or lipopolysaccharide.
Furthermore, in vivo-infected adherent cells obtained from spleens of
L. donovani-infected hamsters caused profound inhibition of
the in vitro antigen-induced proliferative response of lymph node cells
from hamsters immunized with leishmanial antigens. Moreover, this
inhibition was totally abrogated by the anti-TGF-
MAb. These results
suggest that the immunosuppression observed in visceral leishmaniasis
is, at least in part, due to the abundant production of TGF-
during
the course of the infection.
*
Corresponding author. Mailing address for Antonio
Campos-Neto: Infectious Disease Research Institute, 1124 Columbia St.,
Seattle, WA 98104-2015. Phone: (206) 667-5799. Fax: (206) 667-5715. E-mail: acampos{at}corixa.com. Mailing address for
Virmondes Rodrigues, Faculdade de Medicina do Triângulo Mineiro,
Laboratório de Immunologia, Rua Frei Paulino 30, Uberaba, MG
38025-180, Brazil. Phone: 55 34 312-7722. Fax: 55 34 312-6640. E-mail:
vrodrigues{at}mednet.com.br.
This article has been cited by other articles:
-
Dondji, B., Bungiro, R. D., Harrison, L. M., Vermeire, J. J., Bifulco, C., McMahon-Pratt, D., Cappello, M.
(2008). Role for Nitric Oxide in Hookworm-Associated Immune Suppression. Infect. Immun.
76: 2560-2567
[Abstract]
[Full Text]
-
Sen, G., Mukhopadhyay, S., Ray, M., Biswas, T.
(2008). Quercetin interferes with iron metabolism in Leishmania donovani and targets ribonucleotide reductase to exert leishmanicidal activity. J Antimicrob Chemother
61: 1066-1075
[Abstract]
[Full Text]
-
Rama Iniguez, S., Dea-Ayuela, M. A., Sanchez-Brunete, J. A., Torrado, J. J., Alunda, J. M., Bolas-Fernandez, F.
(2006). Real-Time Reverse Transcription-PCR Quantification of Cytokine mRNA Expression in Golden Syrian Hamster Infected with Leishmania infantum and Treated with a New Amphotericin B Formulation.. Antimicrob. Agents Chemother.
50: 1195-1201
[Abstract]
[Full Text]
-
Mookerjee, A., Sen, P. C., Ghose, A. C.
(2003). Immunosuppression in Hamsters with Progressive Visceral Leishmaniasis Is Associated with an Impairment of Protein Kinase C Activity in Their Lymphocytes That Can Be Partially Reversed by Okadaic Acid or Anti-Transforming Growth Factor {beta} Antibody. Infect. Immun.
71: 2439-2446
[Abstract]
[Full Text]
-
Gantt, K. R., Schultz-Cherry, S., Rodriguez, N., Jeronimo, S. M. B., Nascimento, E. T., Goldman, T. L., Recker, T. J., Miller, M. A., Wilson, M. E.
(2003). Activation of TGF-{beta} by Leishmania chagasi: Importance for Parasite Survival in Macrophages. J. Immunol.
170: 2613-2620
[Abstract]
[Full Text]
-
Murray, H. W.
(2001). Clinical and Experimental Advances in Treatment of Visceral Leishmaniasis. Antimicrob. Agents Chemother.
45: 2185-2197
[Full Text]
-
Melby, P. C., Chandrasekar, B., Zhao, W., Coe, J. E.
(2001). The Hamster as a Model of Human Visceral Leishmaniasis: Progressive Disease and Impaired Generation of Nitric Oxide in the Face of a Prominent Th1-Like Cytokine Response. J. Immunol.
166: 1912-1920
[Abstract]
[Full Text]
-
Gomez-Escobar, N., Gregory, W. F., Maizels, R. M.
(2000). Identification of tgh-2, a Filarial Nematode Homolog of Caenorhabditis elegans daf-7 and Human Transforming Growth Factor beta , Expressed in Microfilarial and Adult Stages of Brugia malayi. Infect. Immun.
68: 6402-6410
[Abstract]
[Full Text]
-
Gomes, N. A., Gattass, C. R., Barreto-de-Souza, V., Wilson, M. E., DosReis, G. A.
(2000). TGF-{beta} Mediates CTLA-4 Suppression of Cellular Immunity in Murine Kalaazar. J. Immunol.
164: 2001-2008
[Abstract]
[Full Text]
-
Alexander, J, Satoskar, A., Russell, D.
(1999). Leishmania species: models of intracellular parasitism. J. Cell Sci.
112: 2993-3002
[Abstract]
-
Wilson, M. E., Young, B. M., Davidson, B. L., Mente, K. A., McGowan, S. E.
(1998). The Importance of TGF-{beta} in Murine Visceral Leishmaniasis. J. Immunol.
161: 6148-6155
[Abstract]
[Full Text]